AI MULTIPLIES FOR DRUG DISCOVERY

Summary from the TLDR newsletter

DeepMind restricted AlphaFold 3 on its launch, forbidding the use of the publicly accessible version for drug discovery. This resulted in criticism from the scientific community - but it also spawned many variants and advances. This article looks at some of the breakthroughs that came about due to restrictions in AlphaFold 3. The hybrid architectures built into AlphaFold-like engines may prove to be the path to more streamlined and accurate methods for drug discovery.